FIELD: chemistry.
SUBSTANCE: invention refers to compounds inhibiting formation of c-Myc/Max/DNA complex. Disclosed is a compound corresponding to structural formula 3a or 3b, where R1a-R1d each independently represent a hydrogen atom, halogen or C1-6 alkoxy; R is C1-4 alkyl, isoalkyl, cycloalkyl or phenyl; n is integer from 0 to 2; R4a and R4b each independently represent a hydrogen atom or C1-4 alkyl; Ar is phenyl, 5–6-member heteroaryl or 8–12-member biheteroaryl, and heteroaryl contains at least one or more of N, S and O in a ring, and Ar can be unsubstituted or can be optionally substituted with one or more of the following substitutes: halogen, C1-6 alkyl, C1-6 alkylthio, C1-6 haloalkyl, C1-6 haloalkylthio, C1-6 alkoxy, C1-6 haloalkoxy, nitro group, cyano group, amino group, (C1-6) alkoxy (C1-6) alkylamino group, SF5, S(O)CF3, SCF3, NHC(=O)CH3, C(=O)NHCH3, NHSO2CH3, pyrazole, ester or C1-6 arylcarbonyl. Also presented is a composition containing said compound for treating or preventing bladder cancer.
3a 3b.
EFFECT: technical result is disclosed compounds have inhibitory effect on formation of complex c-Myc/Max/DNA with high selectivity.
4 cl, 6 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTICANCER PHARMACEUTICAL COMPOSITION | 2017 |
|
RU2724340C1 |
HETEROARYL DERIVATIVE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, A METHOD FOR PRODUCTION THEREOF AND A PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH PI3 KINASES, CONTAINING SAID ACTIVE SUBSTANCE | 2016 |
|
RU2719367C2 |
QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING SAME | 2011 |
|
RU2582610C2 |
COMPOUNDS APPLICABLE FOR TREATING AIDS | 2010 |
|
RU2575845C2 |
NEW COMPOUND, METHOD OF ITS PREPARATION AND USE | 2021 |
|
RU2814103C1 |
COMPOUNDS SUITABLE FOR CANCER TREATMENT | 2010 |
|
RU2567752C2 |
HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2711502C2 |
QUINOLINIL-CONTAINING COMPOUND, ITS PHARMACEUTICAL COMPOSITION AND USE | 2020 |
|
RU2803116C2 |
COMPOUNDS APPLICABLE FOR TREATING PREMATURE AGEING AND PARTICULARLY PROGERIA | 2010 |
|
RU2575646C2 |
MULTIFUNCTIONAL QUINOLINE DERIVATIVES AS ANTINEURODEGENERATIVE AGENTS | 2013 |
|
RU2642466C2 |
Authors
Dates
2020-07-21—Published
2017-07-25—Filed